| 中文名称 |
Falecalcitriol
|
| 中文别名 |
氟骨三醇
|
| 英文名称 |
Falecalcitriol
|
| 英文别名 |
Falecalcitriol;(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-Methyl-1-[(2R)-7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;calcitriol hexafluoride;Flocalcitriol;Fulstan;Hornel;Hornel,Fulstan;Ro 23-4194;ST-630
|
| Cas No. |
83805-11-2
|
| 分子式 |
C27H38O3F6
|
| 分子量 |
524.58
|
| 包装储存 |
4°C, protect from light, stored under nitrogen 该产品在溶液状态不稳定,建议您现用现配,即刻使用。
|
| 详情描述 |
Falecalcitriol(Fulstan; Hornel)是骨化三醇类似物,在体内有更高更长久的活性。
|
| 产品详情 |
Falecalcitriol(Fulstan; Hornel)是骨化三醇类似物,在体内有更高更长久的活性。
|
| 生物活性 |
Falecalcitriol(Fulstan; Hornel) is an analog of calcitriol; has a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.
|
| 性状 |
Solid
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
4°C, protect from light, stored under nitrogen 该产品在溶液状态不稳定,建议您现用现配,即刻使用。
|
| 参考文献 |
[1]. Ito H, Ogata H, Yamamoto M, Takahashi K, Shishido K, Takahashi J, Taguchi S, Kinugasa E. Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. Clin Nephro[2]. Tokunaga M, Tamura M, Kabashima N, Serino R, Shibata T, Matsumoto M, Miyamoto T, Miyazaki M, Furuno Y, Takeuchi M, Abe H, Okazaki M, Otsuji Y. Falecalcitriol for conventional vitamin D therapy-resistant secondary hyperparathyroidism in a continuous ambul
|
| 溶解度数据 |
In Vitro: DMSO : 100 mg/mL (190.63 mM; Need ultrasonic)配制储备液
|
[1]. Ito H, Ogata H, Yamamoto M, Takahashi K, Shishido K, Takahashi J, Taguchi S, Kinugasa E. Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. Clin Nephro[2]. Tokunaga M, Tamura M, Kabashima N, Serino R, Shibata T, Matsumoto M, Miyamoto T, Miyazaki M, Furuno Y, Takeuchi M, Abe H, Okazaki M, Otsuji Y. Falecalcitriol for conventional vitamin D therapy-resistant secondary hyperparathyroidism in a continuous ambul
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。